IndiaRF to acquire API and CRAMS business of Ind-Swift Laboratories Limited for INR 1,650 Crores

Mumbai : The Board of Directors of Ind-Swift Laboratories Limited (“Ind-Swift”) on September 6th 2023 approved a business transfer of its active pharmaceutical ingredients (“API”) and contract research and manufacturing services (“CRAMS”) business to

Related Keywords

Japan ,Brazil ,India ,Jammu ,Jammu And Kashmir ,Mumbai ,Maharashtra , ,India Resurgence Fund ,Piramal Enterprises ,Swift Laboratories Limited Ind ,Synthimed Labs Private Limited ,Ind Swift Laboratories Limited ,Piramal Enterprises Limited ,Bain Capital ,